Zhifei Xu
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Oncology top 10%
- Surgery top 10%
- Cancer Research top 10%
- Topics
- Esophageal Cancer Research and Treatment (9 papers)Autophagy in Disease and Therapy (9 papers)PI3K/AKT/mTOR signaling in cancer (8 papers)
- Partner nations
- ChinaUnited StatesBangladesh
In The Last Decade
Zhifei Xu
92 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 125
- Molecular Biology 763
- Pulmonary and Respiratory Medicine 330
- Oncology 322
- Surgery 288
- Cancer Research 193
Countries citing papers authored by Zhifei Xu
This map shows the geographic impact of Zhifei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhifei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhifei Xu more than expected).
Fields of papers citing papers by Zhifei Xu
This network shows the impact of papers produced by Zhifei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhifei Xu. The network helps show where Zhifei Xu may publish in the future.
Co-authorship network of co-authors of Zhifei Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Zhifei Xu. A scholar is included among the top collaborators of Zhifei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhifei Xu. Zhifei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 6 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 31 | |
| 8 | 9 | |
| 9 | 17 | |
| 10 | 5 | |
| 11 | 6 | |
| 12 | 44 | |
| 13 | 34 | |
| 14 | 14 | |
| 15 | 6 | |
| 16 | 2 | |
| 17 | 139 | |
| 18 | 16 | |
| 19 | 111 | |
| 20 | 1 |
About Zhifei Xu
Zhifei Xu is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Oncology, having authored 101 papers that have together received 1.7k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (9 papers), Autophagy in Disease and Therapy (9 papers) and PI3K/AKT/mTOR signaling in cancer (8 papers). The work is most often cited by research in Cancer Research (193 citations), Oncology (322 citations) and Molecular Biology (763 citations). Zhifei Xu has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Peihua Luo, Qiaojun He, Hao Yan, Bo Yang, Xiaochun Yang, Ying Jin, Huanghao Yang, Jian Chen, Jingying Li and Wen Yang. Their work appears in journals such as Angewandte Chemie International Edition, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.